Valbiotis is relying on Amazon France to expand its distribution

The French laboratory Valbiotis, specializing in cardiometabolic health, is embarking on a new phase of growth. Starting October 26, 2026, its ValbiotisPRO® and ValbiotisPLUS® product lines will be available on Amazon France. This decision is part of a multichannel distribution strategy aimed at reaching new consumers beyond pharmacies and the valbiotis.com website.

The expansion towards Amazon responds to a growing trend in the food supplement market in France, estimated at 2 billion euros in 2025. Despite a current share of only 8.3% for online sales, their contribution to growth will reach 28% this year.

This strategy allows Valbiotis to diversify its distribution channels while maintaining control over its pricing policy on Amazon. This ensures the desired positioning for its products, while adapting to changes in the digital market.